Laboratory Medicine ›› 2020, Vol. 35 ›› Issue (1): 33-36.DOI: 10.3969/j.issn.1673-8640.2020.01.008
Previous Articles Next Articles
Received:2019-03-05
Online:2020-01-30
Published:2020-02-28
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2020.01.008
| 组别 | 例数 | MPV/fL | PDW/% | FER/（ng/mL） | Cys C/（mg/L） | 尿素/（mmol/L） | Cr/（μmol/L） |
|---|---|---|---|---|---|---|---|
| 健康对照组 | 50 | 9.54±1.09 | 12.77±1.88 | 75.59±28.11 | 0.77±0.13 | 5.24±1.10 | 64.14±16.55 |
| 单纯SLE组 | 52 | 10.95±1.58* | 13.91±1.52* | 116.94±34.37* | 1.07±0.13* | 5.61±0.82 | 68.02±16.93 |
| 早期LN组 | 50 | 12.17±1.54*# | 14.93±1.75*# | 152.52±28.24*# | 1.41±0.34*# | 5.92±0.89* | 73.10±14.21* |
| LN组 | 48 | 13.27±1.46*#Δ | 16.29±1.28*#Δ | 262.09±105.20*#Δ | 2.78±1.65*#Δ | 8.39±2.45*#Δ | 155.32±64.18*#Δ |
| 组别 | 例数 | MPV/fL | PDW/% | FER/（ng/mL） | Cys C/（mg/L） | 尿素/（mmol/L） | Cr/（μmol/L） |
|---|---|---|---|---|---|---|---|
| 健康对照组 | 50 | 9.54±1.09 | 12.77±1.88 | 75.59±28.11 | 0.77±0.13 | 5.24±1.10 | 64.14±16.55 |
| 单纯SLE组 | 52 | 10.95±1.58* | 13.91±1.52* | 116.94±34.37* | 1.07±0.13* | 5.61±0.82 | 68.02±16.93 |
| 早期LN组 | 50 | 12.17±1.54*# | 14.93±1.75*# | 152.52±28.24*# | 1.41±0.34*# | 5.92±0.89* | 73.10±14.21* |
| LN组 | 48 | 13.27±1.46*#Δ | 16.29±1.28*#Δ | 262.09±105.20*#Δ | 2.78±1.65*#Δ | 8.39±2.45*#Δ | 155.32±64.18*#Δ |
| 项目 | 回归系数 | 标准误 | χ2值 | P值 | OR值 | 95%CI | |
|---|---|---|---|---|---|---|---|
| 下限 | 上限 | ||||||
| MPV | 0.796 | 0.283 | 7.898 | 0.005 | 2.216 | 1.272 | 3.859 |
| PDW | 0.378 | 0.191 | 3.907 | 0.048 | 1.459 | 1.003 | 2.123 |
| FER | 0.027 | 0.009 | 9.405 | 0.002 | 1.207 | 1.010 | 1.045 |
| Cys C | 12.884 | 3.928 | 10.759 | 0.001 | 87.753 | 178.635 | 308.597 |
| 项目 | 回归系数 | 标准误 | χ2值 | P值 | OR值 | 95%CI | |
|---|---|---|---|---|---|---|---|
| 下限 | 上限 | ||||||
| MPV | 0.796 | 0.283 | 7.898 | 0.005 | 2.216 | 1.272 | 3.859 |
| PDW | 0.378 | 0.191 | 3.907 | 0.048 | 1.459 | 1.003 | 2.123 |
| FER | 0.027 | 0.009 | 9.405 | 0.002 | 1.207 | 1.010 | 1.045 |
| Cys C | 12.884 | 3.928 | 10.759 | 0.001 | 87.753 | 178.635 | 308.597 |
| 项目 | AUC（95%CI） | P值 | 临界值 | 敏感性（%） | 特异性（%） | 约登指数 |
|---|---|---|---|---|---|---|
| MPV | 0.718（0.617~0.820） | <0.05 | 11.75 fL | 66.00 | 76.90 | 0.429 |
| PDW | 0.712（0.610~0.814） | <0.05 | 14.75% | 56.00 | 84.60 | 0.406 |
| FER | 0.805（0.718~0.893） | <0.05 | 130.56 ng/mL | 84.00 | 75.00 | 0.590 |
| Cys C | 0.929（0.883~0.974） | <0.05 | 1.24 mg/L | 84.00 | 84.60 | 0.686 |
| 项目 | AUC（95%CI） | P值 | 临界值 | 敏感性（%） | 特异性（%） | 约登指数 |
|---|---|---|---|---|---|---|
| MPV | 0.718（0.617~0.820） | <0.05 | 11.75 fL | 66.00 | 76.90 | 0.429 |
| PDW | 0.712（0.610~0.814） | <0.05 | 14.75% | 56.00 | 84.60 | 0.406 |
| FER | 0.805（0.718~0.893） | <0.05 | 130.56 ng/mL | 84.00 | 75.00 | 0.590 |
| Cys C | 0.929（0.883~0.974） | <0.05 | 1.24 mg/L | 84.00 | 84.60 | 0.686 |
| [1] | 李池慧,郑冰,俞翀曌. 895例系统性红斑狼疮患者自身抗体检测结果的分析[J]. 检验医学,2018,33(5):463-465. |
| [2] | 徐黎明,沈军. 血清瘦素和脂联素联合检测在狼疮性肾炎诊断中的价值[J]. 检验医学,2019,34(5):401-404. |
| [3] | MUANGCHAN C,VAN VOLLENHOVEN R F,BERNATSKY S R,et al. Treatment algorithms in systemic lupus erythematosus[J]. Arthritis Care Res(Hoboken),2015,67(9):1237-1245. |
| [4] | GASPARYAN A Y,AYVAZYAN L,MIKHAILIDIS D P,et al.Mean platelet volume:a link between thrombosis and inflammation?[J]. Curr Pharm Des,2011,17(1):47-58. |
| [5] | 俞虹. 系统性红斑狼疮患者血清FER、CA125的检测及临床意义[J]. 检验医学,2018,33(2):182-184. |
| [6] | ROSÁRIO C,ZANDMAN-GODDARD G,MEYRON-HOLTZ E G,et al.The hyperferritinemic syndrome:macrophage activation syndrome,Still’s disease,septic shock and catastrophic antiphospholipid syndrome[J]. BMC Med,2013,11:185. |
| [7] | KALANTAR-ZADEH K,RODRIGUEZ R A, HUMPHREYS M H.Association between serum ferritin and measures of inflammation,nutrition and iron in haemodialysis patients[J]. Nephrol Dial Transplant,2004,19(1):141-149. |
| [8] | YU C,GERSHWIN M E,CHANG C. Diagnostic criteria for systemic lupus erythematosus:a critical review[J]. J Autoimmun,2014,48-49:10-13. |
| [9] | THANOU A,MERRILL J T.Top 10 things to know about lupus activity measures[J]. Curr Rheumatol Rep,2013,15(6):334. |
| [10] | 杨雪君. 联合检测血清胱抑素C及尿N-乙酰-β-D-葡萄糖苷酶在狼疮性肾炎诊断中的应用[J]. 中国实验诊断学,2018,22(2):244-247. |
| [11] | MING L,JIANG Z,MA J,et al.Platelet-to-lymphocyte ratio,neutrophil-to-lymphocyte ratio,and platelet indices in patients with acute deep vein thrombosis[J]. Vasa,2018,47(2):143-147. |
| [12] | 田培刚,李建华,程青虹. 不同目标血糖管理对脓毒症患者凝血及炎症指标的影响[J]. 石河子科技,2018,43(5):52-55. |
| [13] | 刘守珠,赵海明. PCT、DD和MPV检测在重度急性胰腺炎中的临床价值[J]. 检验医学,2018,33(7):622-625. |
| [14] | KAPSORITAKIS A N,KOUKOURAKIS M I,SFIRIDAKI A,et al.Mean platelet volume:a useful marker of inflammatory bowel disease activity[J]. Am J Gastroenterol,2001,96(3):776-781. |
| [15] | 杨本善,李雪,文江平,等. 60~80岁表观健康人群血清铁蛋白参考区间的建立[J]. 检验医学,2017,32(3):161-164. |
| [16] | AGMON-LEVIN N,ROSÁRIO C,KATZ B S,et al. Ferritin in the antiphospholipid syndrome and its catastrophic variant(cAPS)[J]. Lupus,2013,22(13):1327-1335. |
| [17] | 张如霖,王弘明,彭霞,等. 血清淀粉样蛋白A、胱抑素C与尿白蛋白/肌酐比值联合检测在早期糖尿病肾病中的诊断价值[J]. 检验医学,2018,33(2):97-100. |
| [18] | 李波,王海玉,刘雅洁. NGAL在原发性高血压患者肾功能损伤诊断中的价值[J]. 检验医学,2019,34(5):390-393. |
| [19] | 李礼,胡娟玉,于正清,等. 血清IL-19水平与糖尿病肾病的关系[J]. 检验医学,2017,32(8):691-694. |
| [20] | 程慧,蒋薇,李一,等. 平均血小板体积检测在评估ST段抬高型心肌梗死合并急性肾损伤风险中的意义[J]. 陕西医学杂志,2017,46(10):1477-1478. |
| [21] | 宗晓春,彭一,张贵山,等. 血清铁蛋白与2型糖尿病及糖尿病视网膜病变相关性研究[J]. 河北医科大学学报,2013,34(7):764-766. |
| [22] | 许军英,罗俊辉,杨丽华. 铁蛋白与糖尿病肾病早期微炎症状态的关系[J]. 医学临床研究,2014,31(8):1482-1484. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
